200 related articles for article (PubMed ID: 19765220)
1. Increased bactericidal/permeability increasing protein in patients with cirrhosis.
Guerra-Ruiz A; Casafont F; Cobo M; Terán A; de-la-Peña J; Estebanez A; Pons-Romero F
Liver Int; 2010 Jan; 30(1):94-101. PubMed ID: 19765220
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
Leeuwenberg JF; Dentener MA; Buurman WA
J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
[TBL] [Abstract][Full Text] [Related]
3. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
[TBL] [Abstract][Full Text] [Related]
4. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
[TBL] [Abstract][Full Text] [Related]
5. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.
von der Möhlen MA; van der Poll T; Jansen J; Levi M; van Deventer SJ
J Immunol; 1996 Jun; 156(12):4969-73. PubMed ID: 8648149
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis.
Riordan SM; Skinner N; Nagree A; McCallum H; McIver CJ; Kurtovic J; Hamilton JA; Bengmark S; Williams R; Visvanathan K
Hepatology; 2003 May; 37(5):1154-64. PubMed ID: 12717397
[TBL] [Abstract][Full Text] [Related]
7. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW
J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.
Amura CR; Kamei T; Ito N; Soares MJ; Morrison DC
J Immunol; 1998 Sep; 161(5):2552-60. PubMed ID: 9725255
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of recombinant bovine CD14.
Wang Y; Zarlenga DS; Paape MJ; Dahl GE; Tomita GM
Vet Res; 2003; 34(4):413-21. PubMed ID: 12911858
[TBL] [Abstract][Full Text] [Related]
11. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
[TBL] [Abstract][Full Text] [Related]
13. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
14. [Significance of changes in plasma bactericidal/permeability-increasing protein levels in patients with severe surgical infection].
Zhang LT; Yao YM; Lu JQ; Yu Y
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1342-5. PubMed ID: 18241571
[TBL] [Abstract][Full Text] [Related]
15. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
Zhou H
Zhonghua Shao Shang Za Zhi; 2001 Apr; 17(2):102-4. PubMed ID: 11876922
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.
Tazi KA; Quioc JJ; Saada V; Bezeaud A; Lebrec D; Moreau R
J Hepatol; 2006 Aug; 45(2):280-9. PubMed ID: 16635535
[TBL] [Abstract][Full Text] [Related]
17. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J
J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641
[TBL] [Abstract][Full Text] [Related]
19. Mononuclear cell response to lipopolysaccharide in patients with rheumatoid arthritis: relationship with tristetraprolin expression.
Fabris M; Tolusso B; Di Poi E; Tomietto P; Sacco S; Gremese E; Ferraccioli G
J Rheumatol; 2005 Jun; 32(6):998-1005. PubMed ID: 15940758
[TBL] [Abstract][Full Text] [Related]
20. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
Schumann RR; Lamping N; Hoess A
J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
